Clovis Oncology reports safety data By: MarketMinute.com Stock News October 07, 2016 at 19:57 PM EDT Clovis Oncology Inc. (Nasdaq: CLVS) reported efficacy and safety data from its New Drug Application for rucaparib. The stock price plummeted $6.36 to close at $29.41. Related Stocks: Clovis Oncology Inc